Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Orchestra BioMed Holdings, Inc. (OBIO) had Revenue of $0.87M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$0.87M
Net Income	$-18.75M
Cost of Goods Sold	$0.04M
Gross Profit	$0.82M
Operating Expenses	$19.79M
Operating Income	$-18.92M
Non-Operating Income/Expense	$0.17M
Pre-Tax Income	$-18.75M
Normalized Pre-Tax Income	$-18.75M
Income after Taxes	$-18.75M
Income from Continuous Operations	$-18.75M
Consolidated Net Income/Loss	$-18.75M
Normalized Income after Taxes	$-18.75M
EBIT	$-18.92M
EBITDA	$-18.79M
Weighted-Average Shares Outstanding (Basic)	38.23M
Weighted-Average Shares Outstanding (Diluted)	38.23M
Earnings per Share (EPS) (Basic)	$-0.49
Earnings per Share (EPS) (Diluted)	$-0.49
Balance Sheet Financials
Current Assets	$51.90M
Property, Plant, and Equipment	$1.41M
Long-Term Assets	$7.15M
Total Assets	$59.05M
Current Liabilities	$15.49M
Long-Term Debt	$14.34M
Long-Term Liabilities	$26.70M
Total Liabilities	$42.19M
Common Equity	$16.86M
Tangible Shareholders Equity	$16.86M
Shareholders Equity	$16.86M
Common Shares Outstanding	38.31M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-16.62M
Cash Flow from Investing Activities	$13.00M
Cash Flow from Financial Activities	$-0.30M
Beginning Cash	$22.26M
End Cash	$18.35M
Increase/Decrease in Cash	$-3.91M
Stock-Based Compensation	$2.96M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.46
Debt to Equity Ratio	0.85
Gross Margin	94.93%
Operating Margin	-2179.84%
EBIT Margin	-2179.84%
EBITDA Margin	--
Pre-Tax Profit Margin	-2160.71%
Profit Margin	-2160.71%
Free Cash Flow	$-16.73M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.33
Receiveable Turnover	9.75
Days Sales in Receivables	9.23
Return on Equity	-111.26%
Return on Tangible Equity	-111.26%
Return on Assets	-31.76%
Return on Investments	-60.12%
Book Value Per Share	$0.44
Free Cash Flow per Share	$-0.44
Operating Cash Flow per Share	$-0.43

Data from Zacks Investment Research, Inc.